Corporate Profile
CVRx® is a leader in the development of safe and effective therapies to address unmet needs in cardiovascular disease. Headquartered near Minneapolis, Minn., CVRx is dedicated to improving patient outcomes, quality of life and overall cardiovascular health via our novel baroreceptor neuromodulation therapies.
(Common Stock)
1:25 PM EDT / 04.19.2024
Data Provided by Refinitiv.
Minimum 15 minutes delayed.
Latest Quarterly Earnings
Financial News
Apr 16, 2024
Events
Apr 30, 2024 at 5:00 PM EDT
Jan 25, 2024 at 4:30 PM EST
Jan 10, 2024 at 3:45 PM PST
